Pharma Journalist -

Roche announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve(casirivimab and imdevimab), for the treatment of patients with mild to moderate…
Read More...

BioNTech SE und Kite, a Gilead Company announced the two companies have entered into a purchase agreement for BioNTech to acquire Kite’s solid tumor neoantigen T cell receptor (TCR)…
Read More...

BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, announced that the U.S. Food and Drug Administration (FDA) has granted Fast…
Read More...

RxCelerate, a leading international out-sourced drug discovery and development platform, announced that it has established a venture capital fund, RxCapital, to invest in companies…
Read More...

SMi Group reports: Navigating new legislations and strategies to comply with regulatory requirements The MDR and IVDR updates will have a profound impact on the medical device…
Read More...

SMi Group reports: Exploring the unique challenges and latest breakthroughs in ocular drug development and delivery The global ophthalmic drug market is forecast to surpass $60…
Read More...

Roche announced results from the final analysis of the phase IIIb STASEY study, which confirm the favourable safety profile of Hemlibra (emicizumab), consistent with the phase III HAVEN…
Read More...

AstraZeneca’s Imfinzi (durvalumab) has been approved in China for the 1st-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC), in combination with…
Read More...

LabGenius, a pioneer in the use of machine learning (ML) for protein engineering, today announced the signing of a multi-year research collaboration with Ablynx, a Sanofi company.…
Read More...

Global contract development and manufacturing organisation (CDMO), Recipharm, has announced investment into a new facility in Uttarakhand, India which will see its fill finish capacity…
Read More...